Medimi Past Earnings Performance

Past criteria checks 0/6

Medimi's earnings have been declining at an average annual rate of -2.4%, while the Medical Equipment industry saw earnings growing at 22.9% annually. Revenues have been growing at an average rate of 39.7% per year.

Key information

-2.4%

Earnings growth rate

27.0%

EPS growth rate

Medical Equipment Industry Growth6.2%
Revenue growth rate39.7%
Return on equity-272.3%
Net Margin-300.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Medimi makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NGM:MEDIMI Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 244-13130
30 Jun 244-14140
31 Mar 244-14140
31 Dec 234-14150
30 Sep 233-15150
30 Jun 233-15160
31 Mar 232-15150
31 Dec 222-15150
30 Sep 222-15150
30 Jun 222-16150
31 Mar 221-16150
31 Dec 211-16150
30 Sep 211-15140
30 Jun 211-15130
31 Mar 211-14120
31 Dec 200-14120
30 Sep 201-14110
30 Jun 201-13100
31 Mar 201-13100
31 Dec 191-12100
30 Sep 191-12100
30 Jun 191-12110
31 Mar 190-14120
31 Dec 180-16130
30 Sep 180-21170
30 Jun 180-20170
31 Mar 180-19170
31 Dec 170-19160
30 Sep 170-15130
30 Jun 170-15130
31 Mar 170-14120
31 Dec 160-14120
30 Sep 160-13100
30 Jun 160-1290
31 Mar 160-1070
31 Dec 150-750
30 Sep 150-640
30 Jun 150-640
31 Mar 150-640
31 Dec 140-640
30 Sep 140-740
30 Jun 140-750
31 Mar 140-750

Quality Earnings: MEDIMI is currently unprofitable.

Growing Profit Margin: MEDIMI is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: MEDIMI is unprofitable, and losses have increased over the past 5 years at a rate of 2.4% per year.

Accelerating Growth: Unable to compare MEDIMI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MEDIMI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (31%).


Return on Equity

High ROE: MEDIMI has a negative Return on Equity (-272.29%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 03:40
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medimi AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution